🇺🇸 FDA
Patent

US 6248749

Use of inhibitors of the activity of retinoic acid for treating sensit ive skin and/or acute damage induced by UV radiation

expired A61KA61K31/00A61K31/192

Quick answer

US patent 6248749 (Use of inhibitors of the activity of retinoic acid for treating sensit ive skin and/or acute damage induced by UV radiation) held by Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma
Grant date
Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/00, A61K31/192, A61K31/196, A61K31/202